JP2021520825A5 - - Google Patents

Info

Publication number
JP2021520825A5
JP2021520825A5 JP2020556304A JP2020556304A JP2021520825A5 JP 2021520825 A5 JP2021520825 A5 JP 2021520825A5 JP 2020556304 A JP2020556304 A JP 2020556304A JP 2020556304 A JP2020556304 A JP 2020556304A JP 2021520825 A5 JP2021520825 A5 JP 2021520825A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
hcdr1
hcdr3
Prior art date
Application number
JP2020556304A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021520825A (ja
JPWO2019197675A5 (https=
Filing date
Publication date
Priority claimed from GBGB1806099.6A external-priority patent/GB201806099D0/en
Priority claimed from GBGB1901648.4A external-priority patent/GB201901648D0/en
Application filed filed Critical
Priority claimed from PCT/EP2019/059570 external-priority patent/WO2019197675A1/en
Publication of JP2021520825A publication Critical patent/JP2021520825A/ja
Publication of JP2021520825A5 publication Critical patent/JP2021520825A5/ja
Publication of JPWO2019197675A5 publication Critical patent/JPWO2019197675A5/ja
Pending legal-status Critical Current

Links

JP2020556304A 2018-04-13 2019-04-12 ガレクチン−１０抗体 Pending JP2021520825A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1806099.6A GB201806099D0 (en) 2018-04-13 2018-04-13 Galectin-10 Antibodies
GB1806099.6 2018-04-13
GBGB1901648.4A GB201901648D0 (en) 2019-02-06 2019-02-06 Galectin-10 antibodies
GB1901648.4 2019-02-06
PCT/EP2019/059570 WO2019197675A1 (en) 2018-04-13 2019-04-12 Galectin-10 antibodies

Publications (3)

Publication Number Publication Date
JP2021520825A JP2021520825A (ja) 2021-08-26
JP2021520825A5 true JP2021520825A5 (https=) 2022-04-20
JPWO2019197675A5 JPWO2019197675A5 (https=) 2022-04-20

Family

ID=66240109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020556304A Pending JP2021520825A (ja) 2018-04-13 2019-04-12 ガレクチン−１０抗体

Country Status (12)

Country Link
US (3) US11066473B2 (https=)
EP (1) EP3774905A1 (https=)
JP (1) JP2021520825A (https=)
KR (1) KR20210005070A (https=)
CN (1) CN112166126A (https=)
AU (1) AU2019250689A1 (https=)
BR (1) BR112020020868A2 (https=)
CA (1) CA3094215A1 (https=)
IL (1) IL278010A (https=)
MX (1) MX2020010821A (https=)
SG (1) SG11202009140SA (https=)
WO (1) WO2019197675A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010821A (es) 2018-04-13 2021-01-15 Argenx Iip Bv Anticuerpos contra galectina-10.
US11860114B2 (en) * 2020-03-26 2024-01-02 David Hurwitz Determining atomic coordinates from X-ray diffraction data
WO2021223079A1 (zh) * 2020-05-06 2021-11-11 科稷达隆(北京)生物技术有限公司 一种纳米抗体及其应用
CN113666999B (zh) * 2021-08-31 2022-08-19 中国医学科学院基础医学研究所 用于治疗2型免疫疾病的多肽
CN113667000B (zh) * 2021-08-31 2022-08-19 中国医学科学院基础医学研究所 多肽在制备治疗2型免疫疾病的药物中的应用
CN113999287B (zh) * 2021-12-02 2023-06-27 深圳湾实验室坪山生物医药研发转化中心 一种靶向半乳糖凝集素-10的多肽抑制剂及其制备方法和用途
IL314367A (en) 2022-01-18 2024-09-01 argenx BV Antibodies to galectin 10
KR20240133723A (ko) 2022-01-18 2024-09-04 아르제넥스 비브이 Fab 단편의 분무화
WO2023150260A2 (en) * 2022-02-03 2023-08-10 Regents Of The University Of Minnesota Compounds that target tem8, compositions, and methods
JPWO2023153496A1 (https=) * 2022-02-10 2023-08-17
CN115785245A (zh) * 2022-07-18 2023-03-14 上海博满生物科技有限公司 一种半乳糖凝集素10晶体及其制备的抗体IgY和药物制剂
CN115902204A (zh) * 2022-09-23 2023-04-04 北京大学第三医院（北京大学第三临床医学院） 一种外泌体形式半乳糖凝集素9的检测方法与试剂盒
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
DE10333406A1 (de) * 2003-07-15 2005-02-10 Protagen Ag T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen
GB2461546B (en) 2008-07-02 2010-07-07 Argen X Bv Antigen binding polypeptides
CA2988388C (en) * 2015-04-23 2022-11-22 Nantomics, Llc Cancer neoepitopes
CN106645752B (zh) * 2016-12-27 2018-02-16 中南大学湘雅医院 Galectin‑10及其特异性抗体在制备检测鼻咽癌试剂盒中的应用
MX2020010821A (es) 2018-04-13 2021-01-15 Argenx Iip Bv Anticuerpos contra galectina-10.

Similar Documents

Publication Publication Date Title
JP2021520825A5 (https=)
RU2009107494A (ru) АНТИТЕЛА К ErbB2
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
US20260042850A1 (en) Anti c-met antibodies
US11851460B2 (en) PD1 binding agents
RU2016137110A (ru) Антитела к компоненту комплемента с5
RU2014122990A (ru) Способы комбинированной терапии с применением молекул, связывающихся с psl и pcrv pseudomonas
JP2012532851A5 (https=)
JP2020522280A5 (https=)
JPWO2021139777A5 (https=)
US10975165B2 (en) De-immunised anti-ERBB3 antibodies
JP2019505477A5 (https=)
JPWO2019197675A5 (https=)
CN109721656B (zh) 靶向rankl的治疗性抗体
JP2019528046A5 (https=)
CA3154649A1 (en) Anti-stem cell factor antibodies and methods of use thereof in renal disease
CN112480254B (zh) 抗人白细胞介素-33受体的抗体及其制备方法和应用
JPWO2022111425A5 (https=)
WO2019166596A1 (en) Csf1r binding agents
CN112805297B (zh) 抗人类pd-l1抗体及其用途
IL321677A (en) Anti-PDL1 antibodies, multispecific antibodies, and methods of use
JP2025526279A (ja) 抗ＴＮＦα抗体および組成物
JPWO2019140216A5 (https=)
RU2844744C1 (ru) Антитела против фактора стволовых клеток и способы их применения
JPWO2021055408A5 (https=)